GOAL 3 Kumbatia project 

GOAL 3 is a social enterprise with a vision of fair and accessible healthcare for everyone. Our mission is to enable and empower health workers at places where it is needed most. We want to achieve that through smart, data-driven and user-centred technologies that aids health workers to achieve more with less. Our first product is the algorithm enhanced IMPALA monitoring system for hospitalized children and neonates which we are developing with key opinion leaders and research institutes from Malawi, the UK and the Netherlands. This system will aid health workers to make better risk assessments and prioritize patients and therefore allows them to treat patients better in an early stage and allocate scarce resources more effectively.

Within the ‘Kumbatia’ (Swahili for Embrace) project GOAL 3 focuses on the first steps towards commercialization of the IMPALA monitoring system which is an essential requirement for sustainable and scalable impact. The ultimate goal of this project is to find and utilize our “beachhead” market which will allow us to make the next steps into commercialization at scale. We will use a funneled approach in which we will make the next steps in market exploration. 

The first step will be an in depth market exploration in Kenya, Malawi, Ghana and Rwanda which were selected based on our desk research and interviews. This will lead to improved understanding of the market, market segmentation, understanding of the ecosystem and ultimately selection of the beachhead with its fitted business models. The second step will be the realization of a local establishment that is necessary for creating a local support organization, handling logistics and importation, customer lead generation and ultimately sales and implementation. In this step, GOAL 3 embraces the culture, local workforce, talents and opportunities of the market. In the final step we aim to sell and implement our monitoring systems to our first customers. 

At the end of this project we aim to have 100 monitoring systems running successfully in 3-7 hospitals for a period of 6 months. In addition we will have an in depth analysis and plan for scaling our business that is needed for future funding rounds and sustainable growth. 



A proven business model and validation of the product market fit through a commercial pilot in 3-7 hospitals with 50-100 systems with the following subgoals. This results in the monitoring of an estimated 3500 children and neonates and prevention of an estimated 84 paediatric deaths as well as reduced disability from severe conditions in approximately 140 children.

Additionally, a sustainable and thriving African GOAL 3 department within a viable ecosystem of local and international partners  and a plan for scaling up our business based on the learnings and evaluation of this project will be created.